Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V3BZ
|
||||
| Former ID |
DIB005191
|
||||
| Drug Name |
ME-1071
|
||||
| Synonyms |
CP-3242; MBL inhibitor (intravenous, bacterial infection), Meiji Seika Kaisha; Metallo-beta-lactamase inhibitor (intravenous, bacterial infection), Meiji Seika Kaisha
|
||||
| Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Phase 1 | [548621] | ||
| Company |
Meiji Seika Kaisha Ltd
|
||||
| Canonical SMILES |
CC/C(=C(/C(=O)O)\CC)/C(=O)O
|
||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Inhibitor | [532264] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.